{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:32:44Z","timestamp":1769797964980,"version":"3.49.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"U.S. Food and Drug Administration\u2019s National Center for Toxicological Research"},{"name":"University of Maryland, Baltimore\u2019s participation","award":["U01FD005946"],"award-info":[{"award-number":["U01FD005946"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Molnupiravir (MOV) is a prodrug of N-hydroxycytidine (NHC), an analog of the endogenous ribonucleoside cytidine that can be administered orally. MOV is used for treating patients infected by SARS-CoV-2, the coronavirus responsible for COVID-19. MOV and NHC are mutagenic in bacterial and in mammalian cell cultures, yet both chemicals have been negative or equivocal in nonclinical in vivo models of mutagenesis. We designed and validated a novel error-corrected sequencing (ECS) method for detecting single basepair substitutions in tissue samples obtained from genetically heterogeneous humans. The software used for this ECS method is available for free from a public online repository and it is suitable for analysis of in vivo and in vitro derived samples collected in various experimental scenarios. We recruited two groups of patients having COVID-19 1\u20133\u00a0years ago, one group that received a full course of MOV therapy and the other group (matched for age and COVID-19 diagnosis date) that did not receive MOV. Using the ECS method, we determined the frequencies of basepair substitutions in nucleated cells isolated from peripheral blood of the patients. There was no observed difference in the frequency of mutations, the types of mutations, or mutational spectra between the MOV and the control groups. Also, the spectra of mutations in the MOV group did not show any evidence of the mutational signature expected from exposures to MOV or NHC based on data from mammalian cell culture models. Within the limits of this study, the dose of MOV authorized for the treatment of COVID-19 under emergency use authorization appears to have no mutational consequences for treated patients.<\/jats:p>","DOI":"10.1093\/mutage\/geag002","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:49:09Z","timestamp":1767962949000},"source":"Crossref","is-referenced-by-count":0,"title":["Using error-corrected sequencing for evaluating mutagenicity of molnupiravir in humans"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6886-6546","authenticated-orcid":false,"given":"Page B","family":"McKinzie","sequence":"first","affiliation":[{"name":"Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration , Jefferson, AR 72079 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6261-1470","authenticated-orcid":false,"given":"Rutu R","family":"Valapil","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Maryland , Baltimore, MD 21201 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6644-6684","authenticated-orcid":false,"given":"Emily L","family":"Heil","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Maryland , Baltimore, MD 21201 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5274-4314","authenticated-orcid":false,"given":"James E","family":"Polli","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Maryland , Baltimore, MD 21201 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5404-578X","authenticated-orcid":false,"given":"Meagan B","family":"Myers","sequence":"additional","affiliation":[{"name":"Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration , Jefferson, AR 72079 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6260-9503","authenticated-orcid":false,"given":"Mason G","family":"Pearce","sequence":"additional","affiliation":[{"name":"Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration , Jefferson, AR 72079 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6684-1334","authenticated-orcid":false,"given":"Vasily N","family":"Dobrovolsky","sequence":"additional","affiliation":[{"name":"Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration , Jefferson, AR 72079 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"2026013000215534100_ref1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci Transl Med"},{"key":"2026013000215534100_ref2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0027-5107(78)90189-6","article-title":"The efficiency and extent of mutagenic activity of some new mutagens of base-analogue type","volume":"56","author":"Janion","year":"1978","journal-title":"Mutat Res"},{"key":"2026013000215534100_ref3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0027-5107(80)90218-3","article-title":"N4-hydroxycytidine: a mutagen specific for AT to GC transitions","volume":"72","author":"Janion","year":"1980","journal-title":"Mutat Res"},{"key":"2026013000215534100_ref4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0006-291X(74)90864-X","article-title":"N4-hydroxycytidine-a new mutagen of a base analogue type","volume":"56","author":"Popowska","year":"1974","journal-title":"Biochem Biophys Res Commun"},{"key":"2026013000215534100_ref5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/nar\/2.7.1143","article-title":"The metabolism of N4-hydroxycytidine-a mutagen for Salmonella typhimurium","volume":"2","author":"Popowska","year":"1975","journal-title":"Nucleic Acids Res"},{"key":"2026013000215534100_ref6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/toxsci\/kfae112","article-title":"Comprehensive genotoxicity and carcinogenicity assessment of molnupiravir","volume":"202","author":"Escobar","year":"2024","journal-title":"Toxicol Sci"},{"key":"2026013000215534100_ref7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/em.22510","article-title":"Evaluation of the mutagenic effects of molnupiravir and N4-hydroxycytidine in bacterial and mammalian cells by HiFi sequencing","volume":"63","author":"Miranda","year":"2022","journal-title":"Environ Mol Mutagen"},{"key":"2026013000215534100_ref8","doi-asserted-by":"crossref","first-page":"12031","DOI":"10.1093\/nar\/gkad1002","article-title":"Uridine-cytidine kinase 2 potentiates the mutagenic influence of the antiviral beta-d-N4-hydroxycytidine","volume":"51","author":"Xu","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026013000215534100_ref9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/infdis\/jiab247","article-title":"Beta-d-N4-hydroxycytidine inhibits SARS-CoV-2 through lethal mutagenesis but is also mutagenic to mammalian cells","volume":"224","author":"Zhou","year":"2021","journal-title":"J Infect Dis"},{"key":"2026013000215534100_ref10","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1111\/cts.13395","article-title":"A phase I, randomized, placebo-controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID-19","volume":"15","author":"Nakamura","year":"2022","journal-title":"Clin Transl Sci"},{"key":"2026013000215534100_ref11","doi-asserted-by":"crossref","first-page":"503691","DOI":"10.1016\/j.mrgentox.2023.503691","article-title":"Whole-genome high-fidelity sequencing: a novel approach to detecting and characterization of mutagenicity in vivo","volume":"891","author":"Dobrovolsky","year":"2023","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"2026013000215534100_ref12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/em.22473","article-title":"Genome-wide detection of ultralow-frequency substitution mutations in cultures of mouse lymphoma L5178Y cells and Caenorhabditis elegans worms by PacBio sequencing","volume":"63","author":"Miranda","year":"2022","journal-title":"Environ Mol Mutagen"},{"key":"2026013000215534100_ref13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/toxsci\/kfae104","article-title":"Assessment of in vivo chemical mutagenesis by long-read sequencing","volume":"202","author":"Miranda","year":"2024","journal-title":"Toxicol Sci"},{"key":"2026013000215534100_ref14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/em.22462","article-title":"PacBio sequencing detects genome-wide ultra-low-frequency substitution mutations resulting from exposure to chemical mutagens","volume":"62","author":"Revollo","year":"2021","journal-title":"Environ Mol Mutagen"},{"key":"2026013000215534100_ref15","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","article-title":"Minimap2: pairwise alignment for nucleotide sequences","volume":"34","author":"Li","year":"2018","journal-title":"Bioinformatics"},{"key":"2026013000215534100_ref16","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1093\/bioinformatics\/btv408","article-title":"SomaticSignatures: inferring mutational signatures from single-nucleotide variants","volume":"31","author":"Gehring","year":"2015","journal-title":"Bioinformatics"},{"key":"2026013000215534100_ref17","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2026013000215534100_ref18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"2026013000215534100_ref19","first-page":"10.11.11","article-title":"COSMIC: high-resolution cancer genetics using the catalogue of somatic mutations in cancer","volume":"91","author":"Forbes","year":"2016","journal-title":"Curr Protoc Hum Genet"},{"key":"2026013000215534100_ref20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mrgentox.2009.05.014","article-title":"Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea","volume":"677","author":"Miura","year":"2009","journal-title":"Mutat Res"},{"key":"2026013000215534100_ref21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.toxlet.2025.05.007","article-title":"Germline mutagenicity of molnupiravir and its active form, beta-d-N4-hydroxycytidine, in Caenorhabditis elegans evaluated using whole-genome sequencing","volume":"409","author":"Xia","year":"2025","journal-title":"Toxicol Lett"},{"key":"2026013000215534100_ref22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/toxsci\/kfae156","article-title":"Reader comment on: \u201cComprehensive genotoxicity and carcinogenicity assessment of molnupiravir\u201d","volume":"204","author":"Frederick","year":"2025","journal-title":"Toxicol Sci"},{"key":"2026013000215534100_ref23","first-page":"176","volume-title":"Formulary for Laboratory Animals","author":"Hawk","year":"1999"}],"container-title":["Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mutage\/advance-article-pdf\/doi\/10.1093\/mutage\/geag002\/66323154\/geag002.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mutage\/advance-article-pdf\/doi\/10.1093\/mutage\/geag002\/66323154\/geag002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:22:07Z","timestamp":1769750527000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mutage\/advance-article\/doi\/10.1093\/mutage\/geag002\/8418057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":23,"URL":"https:\/\/doi.org\/10.1093\/mutage\/geag002","relation":{},"ISSN":["0267-8357","1464-3804"],"issn-type":[{"value":"0267-8357","type":"print"},{"value":"1464-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"geag002"}}